Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
2
users have commented on this narrative
19
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Arcturus Therapeutics Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Late-Stage Trials And Vaccine Partnerships Will Strengthen Market Potential
Key Takeaways Advancement in late-stage clinical programs and partnerships positions the company to capture rare disease and vaccine market opportunities, enhancing revenue growth and competitiveness. Operational restructuring and prioritized pipeline extend financial runway, enabling focused investment in high-potential assets while lowering dilution risk and operating expenses.
View narrative
US$70.89
FV
76.0% undervalued
intrinsic discount
33.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
37
users have followed this narrative
Updated
narrative
Owens & Minor
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Patient Direct Model Will Transform Home-Based Health Care Market
Key Takeaways Focusing on higher-margin home-based care and divesting lower-growth segments enhances long-term growth, margin expansion, and free cash flow. Investments in technology, operational efficiency, and targeted acquisitions improve profitability and support ongoing balance sheet strengthening.
View narrative
US$6.28
FV
14.7% undervalued
intrinsic discount
-28.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Northern Data
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Taiga Cloud And NVIDIA Partnership Will Drive Market Transformation
Key Takeaways Strategic expansion into AI and HPC, boosted by partnerships and technology, positions Northern Data to capture revenue growth in the generative AI market. Transitioning to carbon-neutral energy and advanced cooling tech may lower costs, while potential asset sales could fund AI-focused reinvestment.
View narrative
€36.60
FV
50.5% undervalued
intrinsic discount
41.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
Updated
narrative
Americold Realty Trust
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Dubai Expansion And Asia Pacific Demand Will Boost Cold Storage
Key Takeaways Expanding global presence, automation investments, and long-term contracts position Americold to benefit from rising food logistics demand and recurring, stable revenue streams. High barriers to entry, strong partnerships, and disciplined portfolio management support operational efficiency, margin expansion, and future earnings growth.
View narrative
US$21.13
FV
30.3% undervalued
intrinsic discount
5.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
IREN
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Childress And Sweetwater Projects Will Lead A Digital Transformation
Key Takeaways Enhanced vertical integration and strategic energy management position IREN to improve margins and maintain resilience amid industry-wide energy cost pressures. Shifting focus from mining to high-return AI and cloud infrastructure enables faster scaling, higher margins, and better long-term earnings potential than traditional peers.
View narrative
US$22.18
FV
15.6% undervalued
intrinsic discount
57.62%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
82
users have followed this narrative
5 days ago
author updated this narrative
NATL
NCR Atleos
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
ATM Services Will Lead Digital Cash Management Evolution
Key Takeaways Accelerating demand for ATM-as-a-Service and advanced cash management is driving recurring, high-margin revenue growth and expanding the global customer base. Strategic wins, AI-enabled efficiencies, and a strong recurring revenue mix support robust margins, free cash flow, and increasing long-term earnings power.
View narrative
US$44.67
FV
13.1% undervalued
intrinsic discount
4.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Rhythm Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Rising Genetic Diagnosis Will Expand Rare Disease Treatment Pipelines
Key Takeaways Expansion into new indications and age groups, alongside global diagnostic trends, positions Rhythm for sustained patient base and revenue growth. Strong intellectual property and regulatory advantages ensure high margins, pricing power, and long-term resilience against competitive threats.
View narrative
US$112.50
FV
13.6% undervalued
intrinsic discount
68.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
iRhythm Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Population Health And EHR Integration Will Redefine Remote Cardiac Care
Key Takeaways Expanding adoption among primary care and international markets, aided by partnerships and tailored selling models, is fueling sustained volume increases and diversified revenue streams. Investment in advanced product features and AI analytics enhances differentiation and efficiency, supporting recurring usage, improved margins, and scalable long-term profitability.
View narrative
US$178.75
FV
11.3% undervalued
intrinsic discount
17.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Fortrea Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Global Demographic Trends Will Spur Clinical Advances
Key Takeaways Robust global demand, favorable demographic trends, and increased R&D create long-term growth opportunities, while AI investments enable operational efficiency and improved margins. Cost optimization, leadership stability, and renewed focus in key market segments drive business momentum and support sustainable earnings growth.
View narrative
US$7.44
FV
6.1% overvalued
intrinsic discount
0.079%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies